Location: Australia, New South Wales, Sydney
Employees: 11-50
Total raised: $2.7M
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | BlueTree A... | bluetreeal... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.10.2011 | Grant | $2.7M | - |
Mentions in press and media 14
| Date | Title | Description |
| 18.05.2012 | Hand-held eye imaging device from Bioptigen gets 510(k) clearance | The newer hand-held scanner is intended for patients of all ages, including babies and children who may not be as comfortable with the tabletop device. The hand-held Envisu can scan patients whether they are upright or lying down. Canada aw... |
| 28.02.2012 | Handheld eye scanner from Bioptigen gets Health Canada’s regulatory OK | Bioptigen is further developing its technology into a more compact handheld medical device that can be used with premature and neonatal infants, an effort supported by a $2.7 million grant awarded late last year by the National Institutes o... |
| 14.10.2011 | MDT backs iScience Interventional | Funding Roundup | Microcatheter maker iScience Interventional announced an investment by med-tech goliath Medtronic Inc. (NYSE:MDT) to support the commercialization of its drug delivery technologies. The Menlo Park, Calif.-based company’s microcatheter is us... |
| 06.10.2011 | Medical device firm Bioptigen lands $2.7M SBIR grant | “Children have unique eye care needs,” Bioptigen president and CEO Dr. Eric Buckland said in a prepared statement. “It is both exciting and satisfying to work on imaging tailored to the developing eye. Our objective is to provide researcher... |
| 28.03.2011 | Bioptigen signs two partners for eye surgery device development | Bioptigen Inc. added two partners to the company’s effort to develop medical imaging device for eye surgeries. The Research Triangle Park, N.C.-based company intends to combine its imaging technology with research from Irvine, Calif.-based ... |
| 25.03.2011 | N.C. medical device firm Bioptigen finds partners for new eye device | Promoted This Patient Experience Checklist Is Your Key To Success in 2021 As healthcare systems strive to recover from losses due to the pandemic, patient acquisition and retention have never been more urgent, and patient experience has nev... |
| 16.02.2011 | FDA slaps Bioptigen with warning over marketing claims | Medical imaging technology company Bioptigen received a warning from the Food & Drug Administration alleging that the company is marketing its eye imaging scanner without proper approvals. The Research Triangle Park, N.C.-based company ... |
| 16.02.2011 | FDA warns medical imaging firm Bioptigen about marketing claims | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis has undermined the economy and made people with chronic conditions more vulnerable and stressed. Learn more with a new report from Omada Heal... |
| 17.09.2007 | Life sciences briefing: Monday, Sept. 17, 2007 | Featured companies: Bioptigen, Echo Therapeutics, Forest Laboratories, Intrinsic Therapeutics, Microbia, Phreesia, Sontra Medical, TransMedics, Xanthus Pharmaceuticals [NOTE: This is a catchup briefing, posted on 9/28/07. I’ve adjusted the ... |
| - | Hand-held eye imaging device from Bioptigen gets 510(k) clearance | A noninvasive eye imaging system developed by medical device company Bioptigen now has regulatory clearance for use on patients in the United States. Bioptigen received 510(k) clearance from the U.S. Food and Drug Administration for its han... |
Show more